Medevplus is a 4D tomographic imaging technology company for eye diagnostics.
Medevplus developed Ixanner that uses a patented, self-calibrating and self-aligning spectrometer technology in their portable, handheld, and battery-run 4D Optical Coherence Tomography (OCT) device to screen, diagnose, and monitor diseases such as diabetic retinopathy, AMD, glaucoma, Retinopathy of Prematurity (ROP), and retinoblastoma.
Total equity fund: ₹ 2,77,21,487.00. Total grant in aid: ₹ 86,15,000.00. Bitsbicytih Foundation, IKP, VIT, and other University of Houston alumni.
Patent issued number 456317: Self-calibrating spectrometer. Others to be filed: Biometry calculations using single scan method High efficient integrating sphere Miniaturized delay line for OCT AI-based depth calibration Lowest weight high zoom loupe system Efficient method to measure live image quality metric In-line quality assessment along the depth Sub-micron accurate thickness measurements Highly efficient probe for oral cancer detection using OCT
Winner at IKMC 2025 "Born Global" category. NASSCOM Emerge 50 Winners. Naipunya Deeptech Startup Award. X-Pitch Singapore, world's top 100 startups. IKMC 2021 (International Conference) Winners. Government of India funded: BIRAC BIG, Seed, Elevate (GOK). Top 75 innovations during BIRAC's 10 years ceremony. ANSYS Technology Partners. 2019 as Top 10 Deep Tech Hardware Startups - Medtech Innovators Group.
Founder 1 is a PhD from the University of Houston with 5 years of experience developing and selling ophthalmic instruments prior to starting Medevplus. The other founder is a CA Inter with experience in auditing firms such as National Instruments and Bank of Baroda.
